Table 5.

Bivariate and multivariate analysis of alive and retained

		Bivariate analysis			Multivariate analysis
Variable	Category	OR	Confidence interval	p	aOR	Confidence interval	p
Gender	Female	1.32	1.00–1.74	0.047	1.111	0.78–1.57	0.551
	Male	1			1
Age				0.099			0.114
	≤24	1			1
	25–39	1.26	0.70–2.27	0.438	1.90	0.95–3.81	0.071
	40–54	1.03	0.56–1.90	0.911	1.58	0.76–3.27	0.217
	≥55	0.60	0.26–1.38	0.236	0.90	0.32–2.57	0.848
Provider patient volume				0.009			0.015
	<50 patients	1			1
	50–250 patients	1.52	0.87–2.67	0.139	1.79	0.88–3.66	0.110
	>250 patients	0.82	0.52–1.29	0.402	0.83	0.48–1.45	0.513
WHO stage				0.001			0.553
	I	2.40	1.39–4.14	0.002	1.15
	II	2.74	1.48–5.04	0.001	1.80	0.55–2.39	0.711
	III	1.32	0.90–1.92	0.145	1.20	0.80–4.07	0.158
	IV	1			1	0.74–1.93	0.465
ART status				<0.001			<0.001
	Pre-ART: ineligible	1			1
	Pre-ART: eligible	0.49	0.15–1.55	0.227	1.40	0.36–5.46	0.629
	On ART	39.44	14.12–110.19	<0.001	99.40	28.65–344.86	<0.001
TB diagnosis	No	1.32	1.00–1.74	0.043	1.06	0.73–1.55	0.758
	Yes	1			1
CD4 at baseline				<0.001			0.001
	≤50	1			1
	51–200	1.76	1.27–2.44	0.001	1.43	0.95–2.16	0.083
	201–350	2.66	1.85–3.82	<0.001	2.13	1.31–3.49	0.002
	351–500	5.46	2.92–10.21	<0.001	5.77	2.27–14.66	<0.001
	>500	8.10	1.94–33.78	0.004	4.13	0.95–18.02	0.054

aOR, adjusted odds ratio; ART, antiretroviral therapy; CD4, cluster of differentiation 4; OR, odds ratio; TB, tuberculosis.